Parallax Volatility Advisers
MDCO

Parallax Volatility Advisers’s Medicines Co MDCO Stock Holding History

Parallax Volatility Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-176,059
Closed -$8.8M – 2784
2019
Q3 		$8.8M Sell
176,059
-140,099
-44% -$5.59M 0.01% 633
2019
Q2 		$11.5M Sell
316,158
-73,135
-19% -$2.39M 0.01% 485
2019
Q1 		$10.9M Buy
389,293
+381,356
+4,805% +$8.99M 0.01% 456
2018
Q4 		$152K Buy
+7,937
New +$185K ﹤0.01% 1814
2018
Q1 		– Sell
-10,500
Closed -$287K – 5035
2017
Q4 		$287K Sell
10,500
-27,543
-72% -$848K ﹤0.01% 1974
2017
Q3 		$1.41M Buy
+38,043
New +$1.4M ﹤0.01% 951
2017
Q2 		– Sell
-33,100
Closed -$1.47M – 4593
2017
Q1 		$1.62M Buy
+33,100
New +$1.51M ﹤0.01% 943
2016
Q2 		– Sell
-7,386
Closed -$260K – 3908
2016
Q1 		$235K Buy
+7,386
New +$241K ﹤0.01% 1708

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Parallax Volatility Advisers's MDCO Position: Q4 2019 in Review

Parallax Volatility Advisers sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 176,059 shares — an estimated $8.8M sold.

Parallax Volatility Advisers first reported a position in MDCO in Q1 2016 and held it in 8 quarters. The position peaked at $11.5M in Q2 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Parallax Volatility Advisers reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 176,059 Medicines Co shares in Q4 2019, an estimated $8.8M.
  • Parallax Volatility Advisers first reported a position in Medicines Co in Q1 2016 and held it in 8 quarters.
  • Parallax Volatility Advisers's Medicines Co position peaked at $11.5M in Q2 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Parallax Volatility Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.